Neuberger Berman Group’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-604,219
Closed -$16.1M 1984
2021
Q3
$16.1M Sell
604,219
-361,833
-37% -$8.95M 0.01% 734
2021
Q2
$16.5M Sell
966,052
-22,366
-2% -$419K 0.01% 744
2021
Q1
$20.5M Sell
988,418
-54,804
-5% -$1.26M 0.02% 680
2020
Q4
$23.8M Buy
1,043,222
+119,745
+13% +$2.28M 0.02% 591
2020
Q3
$15.1M Sell
923,477
-13,312
-1% -$241K 0.02% 647
2020
Q2
$12.7M Sell
936,789
-25,394
-3% -$295K 0.02% 674
2020
Q1
$11.4M Buy
962,183
+280,887
+41% +$6.23M 0.02% 627
2019
Q4
$17M Buy
681,296
+25,334
+4% +$513K 0.02% 634
2019
Q3
$11.2M Buy
655,962
+156,505
+31% +$2.85M 0.01% 695
2019
Q2
$11.4M Buy
499,457
+164,014
+49% +$4.42M 0.01% 735
2019
Q1
$10.8M Sell
335,443
-26,780
-7% -$829K 0.01% 726
2018
Q4
$10.2M Buy
362,223
+25,564
+8% +$749K 0.01% 727
2018
Q3
$9.68M Buy
336,659
+30,029
+10% +$902K 0.01% 802
2018
Q2
$11.5M Sell
306,630
-225,639
-42% -$8.86M 0.01% 777
2018
Q1
$20.9M Sell
532,269
-195,691
-27% -$7.15M 0.02% 624
2017
Q4
$23.6M Sell
727,960
-74,561
-9% -$2.24M 0.03% 594
2017
Q3
$25M Buy
802,521
+59,620
+8% +$1.76M 0.03% 563
2017
Q2
$20.8M Sell
742,901
-141,726
-16% -$3.21M 0.03% 600
2017
Q1
$15.2M Buy
884,627
+293,949
+50% +$4.12M 0.02% 661
2016
Q4
$7.15M Buy
+590,678
New +$7.65M 0.01% 808
2015
Q4
Sell
-47,900
Closed -$1.12M 1590
2015
Q3
$1.12M Buy
47,900
+9,900
+26% +$273K ﹤0.01% 1141
2015
Q2
$1.09M Buy
+38,000
New +$996K ﹤0.01% 1193

Other funds holding XENT

Neuberger Berman Group's XENT Position: Q4 2021 in Review

Neuberger Berman Group sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 604,219 shares — an estimated $16.1M sold.

Neuberger Berman Group first reported a position in XENT in Q2 2015 and held it in 22 quarters. The position peaked at $25M in Q3 2017. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Neuberger Berman Group reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 604,219 Intersect ENT, Inc shares in Q4 2021, an estimated $16.1M.
  • Neuberger Berman Group first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 22 quarters.
  • Neuberger Berman Group's Intersect ENT, Inc position peaked at $25M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Neuberger Berman Group's 13F filing for Q4 2021, filed 11 Feb 2022.